Pharmaceutical News and Articles

Boehringer’s Zongertinib Receives Priority Review from U.S. FDA for the Treatment of HER2 (ERBB2)-Mutant Advanced Non-Small Cell Lung Cancer

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its new drug application for zongertinib (B

Clarity Receives US FDA Fast Track Designation for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients with Cu-67 SAR-bisPSMA

Sydney, Australia 19 February 2025 Clarity Pharmaceuticals (ASX CU6) ( Clarity or Company ), a clinical-stage radiopharmaceutical company with a mission to deve

PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia

American Stroke Association, Feb. 5-7

Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation, according to a study presented at the annual Amer

FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes

The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients w

Unhealthy Eating Linked To Female Incontinence

A junk-food lifestyle might contribute to embarrassing little leaks in middle-aged women, a new study suggests. Women who often munch fast food or packaged eats

Denied by Insurance? Why Fighting Back Sometimes Works

After three years, 40,000 in medical bills and five insurance denials, April and Justin Beck finally won their battle to get life-changing treatment for their 9

Calls to Poison Centers on the Rise for Pediatric Exposures to Caffeine Energy Products

Pediatric exposures to caffeine energy products reported to U.S. poison centers increased from 2011 to 2023, although most exposures had minimal clinical effect

De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibi

Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer

For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR) gene alterations, talazoparib (TA